The neurlink brain chip of Elon Musk was transplanted in 2 quadrilateral canadian patients as part of the clinkal trial
Two Canadian patients with spinal injuries have received neurlink brain implants who have allowed them to control a computer with their ideas.
They are part of the first clinical trial outside the United States to test the safety and effectiveness of the neurlink wireless brain chip of Elon Musk, which he introduced to the public in 2020, and was first transplanted into a paralyzed American in 2024.
Canadian men, about 30 years old – from one Ontario, another from Alberta – did not have the ability to use or use their hands.
A neurosurgeon of University Health Network, which led the surgical team at Toronto Western Hospital, Dr. Andres Lozano said that patients can take almost computer cursors immediately after surgery. He said that both of them were able to leave the hospital in the morning after their respective procedures on 27 August and 3 September.
Lozano explained that the electrode was implanted to use neuron signals in the motor region of each patient and translated those signals in functions on external equipment, left at the need to physically move, Lozano explained.
He said, “The first patient was able to control a curse by thinking within a few minutes. It is very fast. The signals are decoded and read artificial intelligence signals and then translates them into movement on the cursor,” he said.
“They just think about it and it happens.”
Tempering expectations
Brain-computers interface (BCI) devices are not exclusive to neurlinks, and other companies such as the New-York-based synchron are conducting their own clinical trials.
Barry Munro, Chief Development Officer of Canadian Spinal Research Organization, said that the promise of this technology is encouraging, but expectations should be noted.
Munro, who has been quadrilateral since a diving accident 38 years ago, said that he has dedicated his life to spinal injury research, and helped recruiting neurlinks to American testing.
The first person to receive the device last year has publicly stated that it has started slipping from the weeks of his brain after surgery, setting his progress back, but he is then stable and it is still meaningful.
Munro says that he has seen “false hope” time in the region and again and encouraged “educated Asha” instead – to be excited to be excited to learn and get excited without expecting such a transplant within the next six months.
“We are not there yet, it’s all,” he said.
The first human patient has found a transplant from the Computer-Brain Interface Company of Elon Musk, Elon Musk. Andrew Chang examines the complexity of the N1 implant, how it is working in clinical trials, and trying to achieve what the neurlink device.
Clinical test safety, evaluates quality of life
Canadian patients will be monitored for at least one year, allowing one and four patients in the country to enroll with the clinical research team, either paralyzed by spinal injury or who have amiotrophic lateral sclerosis (ALS).
The clinical trial team will be evaluated as to whether the technology is safe and if it adds value to the quality of life of the patient. Side effects they may be searching, including seizures, infections or strokes.
In the coming weeks and months, the patients will learn to type on the computer without touching a keyboard. Already, they are capable of playing video games.
“This is really an initial step to see if it should be extended and rolled to a large population,” Lozano
Said.
“Right now the device is a cursor, but in the future you can drive a car, you can drive your wheelchair, you can run a robot.”
